Caspase-6 activation in familial alzheimer disease brains carrying amyloid precursor protein or presenilin i or presenilin II mutations

Journal of Neuropathology and Experimental Neurology

Volumn 68, Issue 12, 2009, Pages 1282-1293

  Albrecht, Steffen ^a,b   Bogdanovic, Nenad ^c   Ghetti, Bernardino ^d   Winblad, Bengt ^c   Leblanc, Andréa C ^a,e  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

^c KAROLINSKA INSTITUTE   (Sweden)

^d INDIANA UNIVERSITY   (United States)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

Alzheimer disease; Arctic mutation; Casp 6; Familial Alzheimer disease; Presenilin I mutation; Sporadic Alzheimer disease; Swedish mutation; Tau cleaved by Casp 6

Indexed keywords

AMYLOID PROTEIN; CASPASE 6; PRESENILIN 1; PRESENILIN 2; TAU PROTEIN; AMYLOID PRECURSOR PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NEUROFIBRILLARY TANGLE; NEUROPIL THREAD; PRIORITY JOURNAL; TEMPORAL CORTEX; ADULT; BRAIN; ENZYME ACTIVATION; ENZYMOLOGY; GENETICS; METABOLISM; MIDDLE AGED; MUTATION; PATHOLOGY; PHYSIOLOGY; SENILE PLAQUE;

ADULT; AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; BRAIN; CASPASE 6; ENZYME ACTIVATION; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUTATION; NEUROFIBRILLARY TANGLES; NEUROPIL THREADS; PRESENILIN-1; PRESENILIN-2; SENILE PLAQUES;

EID: 73349135640     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3181c1da10     Document Type: Article

References (25)

1. Creagh EM, Conroy H, Martin SJ. Caspase-activation pathways in apoptosis and immunity. Immunol Rev 2003;193:10-21
2. Gervais F, Xu D, Robertson G, et al. Involvement of caspases in pro-teolytic cleavage of Alzheimer's A-amyloid precursor protein and amyloidogenic A-peptide formation. Cell 1999;97:395-406
3. LeBlanc AC, Liu H, Goodyer C, et al. Caspase-6 role in apoptosis of human neurons, amyloidogenesis and Alzheimer's disease. J Biol Chem 1999;274:23426-23436
4. Tesco G, Koh YH, Tanzi RE. Caspase activation increases beta-amyloid generation independently of caspase cleavage of the beta-amyloid precursor protein (APP). J Biol Chem 2003;278:4607-4680
5. Guo H, Albrecht S, Bourdeau M, et al. Active caspase-6 and caspase-6 cleaved tau in neuropil threads, neuritic plaques and neurofibrillary tangles of Alzheimer's disease. Am J Pathol 2004;165:523-531
6. Albrecht S, Bourdeau M, Bennett D, et al. Activation of caspase-6 in aging and mild cognitive impairment. Am J Pathol 2007;170:1200-1209 (Pubitemid 47339328)
7. Zhang Y, Goodyer C, LeBlanc A. Selective and protracted apoptosis in human primary neurons microinjected with active caspase-3,-6,-7, and-8. J Neurosci 2000;20:8384-8389
8. Klaiman G, Champagne N, LeBlanc AC. Self-activation of caspase-6 in vitro and in vivo: Caspase-6 activation does not induce cell death in HEK293T cells. Biochim Biophys Acta 2009;1793:592-601
9. Ruchaud S, Korfali N, Villa P, et al. Caspase-6 gene disruption reveals a requirement for lamin A cleavage in apoptotic chromatin condensation. EMBO J 2002;21:1967-1977
10. Klaiman G, Petzke TL, Hammond J, et al. Targets of caspase-6 activity in human neurons and Alzheimer disease. Mol Cell Proteomics 2008;7: 1541-1555
11. Nikolaev A, McLaughlin T, O'Leary DD, et al. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 2009; 457:981-989
12. LeBlanc A. Increased production of 4 kDa amyloid beta peptide in serum deprived human primary neuron cultures: Possible involvement of apoptosis. J Neurosci 1995;15:7837-7846
13. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). 2. Standardization of the neu-ropathologic assessment of Alzheimer's disease. Neurol 1991;41:479-486
14. Houlden H, Baker M, McGowan E, et al. Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations. Ann Neurol 2000;48:806-808
15. Miravalle L, Calero M, Takao M, et al. Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques. Biochemistry 2005;44:10810-10821
16. Tabira T, Chui DH, Nakayama H, et al. Alzheimer's disease with spastic paresis and cotton wool type plaques. J Neurosci Res 2002;70:367-372
17. Basun H, Bogdanovic N, Ingelsson M, et al. Clinical and neuropa-thological features of the arctic APP gene mutation causing early-onset Alzheimer disease. Arch Neurol 2008;65:499-505
18. Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med 2004;(suppl 10):S10-17
19. MacFarlane M, Merrison W, Dinsdale D, et al. Active caspases and cleaved cytokeratins are sequestered into cytoplasmic inclusions in TRAIL-induced apoptosis. J Cell Biol 2000;148:1239-1254
20. Dinsdale D, Lee JC, Dewson G, et al. Intermediate filaments control the intracellular distribution of caspases during apoptosis. Am J Pathol 2004; 164:395-407
21. Zhang Y, McLaughlin R, Goodyer C, et al. Selective cytotoxicity of intracellular amyloid b peptide1-42 through p53 and bax in cultured primary human neurons. J Cell Biol 2002;156:519-529
22. Cheng IH, Scearce-Levie K, Legleiter J, et al. Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. J Biol Chem 2007;282:23818-23828
23. Cheng IH, Palop JJ, Esposito LA, et al. Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation. Nat Med 2004;10:1190-1192
24. MacLachlan TK, El-Deiry WS. Apoptotic threshold is lowered by p53 transactivation of caspase-6. Proc Natl Acad Sci U S A 2002;99:9492-9497
25. Raina AK, Hochman A, Zhu X, et al. Abortive apoptosis in Alzheimer's disease. Acta Neuropathol (Berl) 2001;101:305-310